Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091850
Filing Date
2024-08-06
Accepted
2024-08-06 16:20:28
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20240630.htm   iXBRL 10-Q 1793854
2 EX-31.1 rptx-ex31_1.htm EX-31.1 15469
3 EX-31.2 rptx-ex31_2.htm EX-31.2 15438
4 EX-32.1 rptx-ex32_1.htm EX-32.1 12905
5 GRAPHIC img194142222_0.jpg GRAPHIC 79534
  Complete submission text file 0000950170-24-091850.txt   7426186

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20240630.xsd EX-101.SCH 947017
62 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20240630_htm.xml XML 1363250
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 241179613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)